ID   PRPK_HUMAN              Reviewed;         253 AA.
AC   Q96S44; B3KU44; Q3T977; Q5JZ01; Q6NZ60; Q96FM7; Q9NQE6;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2002, sequence version 2.
DT   12-OCT-2022, entry version 186.
DE   RecName: Full=EKC/KEOPS complex subunit TP53RK {ECO:0000305};
DE            EC=3.6.-.- {ECO:0000250|UniProtKB:Q9UYB9};
DE   AltName: Full=Atypical serine/threonine protein kinase TP53RK {ECO:0000303|PubMed:11546806};
DE   AltName: Full=Nori-2 {ECO:0000312|HGNC:HGNC:16197};
DE   AltName: Full=TP53-regulating kinase {ECO:0000312|HGNC:HGNC:16197};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:11546806};
DE   AltName: Full=p53-related protein kinase {ECO:0000303|PubMed:11546806};
GN   Name=TP53RK {ECO:0000312|HGNC:HGNC:16197};
GN   Synonyms=C20orf64, PRPK {ECO:0000303|Ref.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Spleen;
RX   PubMed=11546806; DOI=10.1074/jbc.m105669200;
RA   Abe Y., Matsumoto S., Wei S., Nezu K., Miyoshi A., Kito K., Ueda N.,
RA   Shigemoto K., Hitsumoto Y., Nikawa J., Enomoto Y.;
RT   "Cloning and characterization of a p53-related protein kinase expressed in
RT   interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and
RT   the testes.";
RL   J. Biol. Chem. 276:44003-44011(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-25.
RA   Abe Y.;
RT   "PRPK mutant.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH TPRKB.
RX   PubMed=12659830; DOI=10.1016/s0006-291x(03)00333-4;
RA   Miyoshi A., Kito K., Aramoto T., Abe Y., Kobayashi N., Ueda N.;
RT   "Identification of CGI-121, a novel PRPK (p53-related protein kinase)-
RT   binding protein.";
RL   Biochem. Biophys. Res. Commun. 303:399-405(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-135, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34 AND THR-135, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN THE EKC/KEOPS COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=22912744; DOI=10.1371/journal.pone.0042822;
RA   Costessi A., Mahrour N., Sharma V., Stunnenberg R., Stoel M.A., Tijchon E.,
RA   Conaway J.W., Conaway R.C., Stunnenberg H.G.;
RT   "The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by
RT   the human tumour antigen PRAME.";
RL   PLoS ONE 7:E42822-E42822(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION IN THE EKC/KEOPS COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=27903914; DOI=10.1093/nar/gkw1181;
RA   Wan L.C., Maisonneuve P., Szilard R.K., Lambert J.P., Ng T.F., Manczyk N.,
RA   Huang H., Laister R., Caudy A.A., Gingras A.C., Durocher D., Sicheri F.;
RT   "Proteomic analysis of the human KEOPS complex identifies C14ORF142 as a
RT   core subunit homologous to yeast Gon7.";
RL   Nucleic Acids Res. 45:805-817(2017).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-123; ALA-129 AND ALA-145.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [16]
RP   INVOLVEMENT IN GAMOS4, VARIANTS GAMOS4 ASP-42; ARG-81 AND LEU-243,
RP   IDENTIFICATION IN THE EKC/KEOPS COMPLEX, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION OF VARIANT GAMOS4 ARG-81.
RX   PubMed=28805828; DOI=10.1038/ng.3933;
RA   Braun D.A., Rao J., Mollet G., Schapiro D., Daugeron M.C., Tan W.,
RA   Gribouval O., Boyer O., Revy P., Jobst-Schwan T., Schmidt J.M.,
RA   Lawson J.A., Schanze D., Ashraf S., Ullmann J.F.P., Hoogstraten C.A.,
RA   Boddaert N., Collinet B., Martin G., Liger D., Lovric S., Furlano M.,
RA   Guerrera I.C., Sanchez-Ferras O., Hu J.F., Boschat A.C., Sanquer S.,
RA   Menten B., Vergult S., De Rocker N., Airik M., Hermle T., Shril S.,
RA   Widmeier E., Gee H.Y., Choi W.I., Sadowski C.E., Pabst W.L., Warejko J.K.,
RA   Daga A., Basta T., Matejas V., Scharmann K., Kienast S.D., Behnam B.,
RA   Beeson B., Begtrup A., Bruce M., Ch'ng G.S., Lin S.P., Chang J.H.,
RA   Chen C.H., Cho M.T., Gaffney P.M., Gipson P.E., Hsu C.H., Kari J.A.,
RA   Ke Y.Y., Kiraly-Borri C., Lai W.M., Lemyre E., Littlejohn R.O., Masri A.,
RA   Moghtaderi M., Nakamura K., Ozaltin F., Praet M., Prasad C., Prytula A.,
RA   Roeder E.R., Rump P., Schnur R.E., Shiihara T., Sinha M.D., Soliman N.A.,
RA   Soulami K., Sweetser D.A., Tsai W.H., Tsai J.D., Topaloglu R., Vester U.,
RA   Viskochil D.H., Vatanavicharn N., Waxler J.L., Wierenga K.J., Wolf M.T.F.,
RA   Wong S.N., Leidel S.A., Truglio G., Dedon P.C., Poduri A., Mane S.,
RA   Lifton R.P., Bouchard M., Kannu P., Chitayat D., Magen D., Callewaert B.,
RA   van Tilbeurgh H., Zenker M., Antignac C., Hildebrandt F.;
RT   "Mutations in KEOPS-complex genes cause nephrotic syndrome with primary
RT   microcephaly.";
RL   Nat. Genet. 49:1529-1538(2017).
CC   -!- FUNCTION: Component of the EKC/KEOPS complex that is required for the
CC       formation of a threonylcarbamoyl group on adenosine at position 37
CC       (t(6)A37) in tRNAs that read codons beginning with adenine
CC       (PubMed:22912744, PubMed:27903914). The complex is probably involved in
CC       the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-AMP
CC       (TC-AMP) to the N6 group of A37 (PubMed:22912744, PubMed:27903914).
CC       TP53RK has ATPase activity in the context of the EKC/KEOPS complex and
CC       likely plays a supporting role to the catalytic subunit OSGEP (By
CC       similarity). Atypical protein kinase that phosphorylates 'Ser-15' of
CC       p53/TP53 protein and may therefore participate in its activation
CC       (PubMed:11546806). {ECO:0000250|UniProtKB:P53323,
CC       ECO:0000250|UniProtKB:Q9UYB9, ECO:0000269|PubMed:11546806,
CC       ECO:0000305|PubMed:22912744, ECO:0000305|PubMed:27903914}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:11546806};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11546806};
CC   -!- SUBUNIT: Component of the EKC/KEOPS complex composed of at least GON7,
CC       TP53RK, TPRKB, OSGEP and LAGE3; the whole complex dimerizes.
CC       {ECO:0000269|PubMed:12659830, ECO:0000269|PubMed:22912744,
CC       ECO:0000269|PubMed:27903914, ECO:0000269|PubMed:28805828}.
CC   -!- INTERACTION:
CC       Q96S44; Q13137: CALCOCO2; NbExp=5; IntAct=EBI-739588, EBI-739580;
CC       Q96S44; Q9H8Y8: GORASP2; NbExp=3; IntAct=EBI-739588, EBI-739467;
CC       Q96S44; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-739588, EBI-742948;
CC       Q96S44; Q9NPF4: OSGEP; NbExp=4; IntAct=EBI-739588, EBI-1056510;
CC       Q96S44; Q9Y3C4: TPRKB; NbExp=5; IntAct=EBI-739588, EBI-750123;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:28805828}. Nucleus
CC       {ECO:0000269|PubMed:22912744, ECO:0000269|PubMed:27903914,
CC       ECO:0000269|PubMed:28805828}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Weakly expressed in
CC       heart kidney and spleen. {ECO:0000269|PubMed:11546806}.
CC   -!- DOMAIN: This protein is considered an atypical serine/threonine kinase,
CC       because it lacks the conventional structural elements necessary for the
CC       substrate recognition as well as a lysine residue that in all other
CC       serine/threonine kinases participates in the catalytic event. TP53RK
CC       has protein kinase activity in vitro, but in the context of the
CC       EKC/KEOPS complex, the catalytic subunit OSGEP switches the activity of
CC       TP53RK from kinase into ATPase (By similarity).
CC       {ECO:0000250|UniProtKB:P53323, ECO:0000250|UniProtKB:Q9UYB9}.
CC   -!- DISEASE: Galloway-Mowat syndrome 4 (GAMOS4) [MIM:617730]: A form of
CC       Galloway-Mowat syndrome, a severe renal-neurological disease
CC       characterized by early-onset nephrotic syndrome associated with
CC       microcephaly, central nervous system abnormalities, developmental
CC       delays, and a propensity for seizures. Brain anomalies include gyration
CC       defects ranging from lissencephaly to pachygyria and polymicrogyria,
CC       and cerebellar hypoplasia. Most patients show facial dysmorphism
CC       characterized by a small, narrow forehead, large/floppy ears, deep-set
CC       eyes, hypertelorism and micrognathia. Additional variable features are
CC       visual impairment and arachnodactyly. Most patients die in early
CC       childhood. {ECO:0000269|PubMed:28805828}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. BUD32 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB017505; BAB61875.2; -; mRNA.
DR   EMBL; AB065434; BAB62041.1; -; mRNA.
DR   EMBL; AK096502; BAG53306.1; -; mRNA.
DR   EMBL; AL031055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133520; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75727.1; -; Genomic_DNA.
DR   EMBL; BC009727; AAH09727.1; -; mRNA.
DR   EMBL; BC010637; AAH10637.1; -; mRNA.
DR   EMBL; BC066309; AAH66309.1; -; mRNA.
DR   CCDS; CCDS13401.1; -.
DR   RefSeq; NP_291028.3; NM_033550.3.
DR   PDB; 6WQX; X-ray; 2.53 A; C/D=1-253.
DR   PDBsum; 6WQX; -.
DR   AlphaFoldDB; Q96S44; -.
DR   SMR; Q96S44; -.
DR   BioGRID; 125211; 74.
DR   CORUM; Q96S44; -.
DR   IntAct; Q96S44; 28.
DR   STRING; 9606.ENSP00000361186; -.
DR   ChEMBL; CHEMBL1938223; -.
DR   GlyGen; Q96S44; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q96S44; -.
DR   PhosphoSitePlus; Q96S44; -.
DR   BioMuta; TP53RK; -.
DR   DMDM; 26398348; -.
DR   EPD; Q96S44; -.
DR   jPOST; Q96S44; -.
DR   MassIVE; Q96S44; -.
DR   MaxQB; Q96S44; -.
DR   PaxDb; Q96S44; -.
DR   PeptideAtlas; Q96S44; -.
DR   PRIDE; Q96S44; -.
DR   ProteomicsDB; 78064; -.
DR   Antibodypedia; 2100; 306 antibodies from 24 providers.
DR   DNASU; 112858; -.
DR   Ensembl; ENST00000372114.4; ENSP00000361186.3; ENSG00000172315.6.
DR   GeneID; 112858; -.
DR   KEGG; hsa:112858; -.
DR   MANE-Select; ENST00000372114.4; ENSP00000361186.3; NM_033550.4; NP_291028.3.
DR   UCSC; uc002xsk.4; human.
DR   CTD; 112858; -.
DR   DisGeNET; 112858; -.
DR   GeneCards; TP53RK; -.
DR   HGNC; HGNC:16197; TP53RK.
DR   HPA; ENSG00000172315; Low tissue specificity.
DR   MalaCards; TP53RK; -.
DR   MIM; 608679; gene.
DR   MIM; 617730; phenotype.
DR   neXtProt; NX_Q96S44; -.
DR   OpenTargets; ENSG00000172315; -.
DR   Orphanet; 2065; Galloway-Mowat syndrome.
DR   PharmGKB; PA25774; -.
DR   VEuPathDB; HostDB:ENSG00000172315; -.
DR   eggNOG; KOG3087; Eukaryota.
DR   GeneTree; ENSGT00390000012914; -.
DR   HOGENOM; CLU_063953_0_0_1; -.
DR   InParanoid; Q96S44; -.
DR   OMA; HKLYMEY; -.
DR   OrthoDB; 1425238at2759; -.
DR   PhylomeDB; Q96S44; -.
DR   TreeFam; TF325502; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q96S44; -.
DR   Reactome; R-HSA-6782315; tRNA modification in the nucleus and cytosol.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   SignaLink; Q96S44; -.
DR   SIGNOR; Q96S44; -.
DR   BioGRID-ORCS; 112858; 642 hits in 1047 CRISPR screens.
DR   ChiTaRS; TP53RK; human.
DR   GeneWiki; TP53RK; -.
DR   GenomeRNAi; 112858; -.
DR   Pharos; Q96S44; Tbio.
DR   PRO; PR:Q96S44; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q96S44; protein.
DR   Bgee; ENSG00000172315; Expressed in ventricular zone and 157 other tissues.
DR   ExpressionAtlas; Q96S44; baseline and differential.
DR   Genevisible; Q96S44; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0000408; C:EKC/KEOPS complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0002039; F:p53 binding; IDA:HGNC-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0008033; P:tRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0070525; P:tRNA threonylcarbamoyladenosine metabolic process; IBA:GO_Central.
DR   InterPro; IPR022495; Bud32.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   PANTHER; PTHR12209; PTHR12209; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   TIGRFAMs; TIGR03724; arch_bud32; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Disease variant; Epilepsy; Hydrolase;
KW   Intellectual disability; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; tRNA processing.
FT   CHAIN           1..253
FT                   /note="EKC/KEOPS complex subunit TP53RK"
FT                   /id="PRO_0000088190"
FT   DOMAIN          33..253
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           78..95
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        162
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         39..47
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         60
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         135
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195"
FT   VARIANT         25
FT                   /note="A -> T"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_014427"
FT   VARIANT         42
FT                   /note="G -> D (in GAMOS4; dbSNP:rs773814837)"
FT                   /evidence="ECO:0000269|PubMed:28805828"
FT                   /id="VAR_080371"
FT   VARIANT         81
FT                   /note="T -> R (in GAMOS4; abolished interaction with TPRKB;
FT                   dbSNP:rs1432218739)"
FT                   /evidence="ECO:0000269|PubMed:28805828"
FT                   /id="VAR_080372"
FT   VARIANT         123
FT                   /note="R -> Q (in dbSNP:rs34983477)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041881"
FT   VARIANT         129
FT                   /note="T -> A (in dbSNP:rs11550540)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_030870"
FT   VARIANT         145
FT                   /note="T -> A (in dbSNP:rs56008408)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041882"
FT   VARIANT         243
FT                   /note="R -> L (in GAMOS4; dbSNP:rs776588426)"
FT                   /evidence="ECO:0000269|PubMed:28805828"
FT                   /id="VAR_080373"
FT   CONFLICT        51
FT                   /note="R -> H (in Ref. 6; AAH66309)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93
FT                   /note="R -> L (in Ref. 6; AAH10637)"
FT                   /evidence="ECO:0000305"
FT   HELIX           19..33
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          46..52
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          55..61
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          66..68
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           70..93
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   TURN            106..109
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          110..114
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           122..132
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          133..136
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           140..155
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          165..170
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           174..176
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   STRAND          179..181
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           193..210
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           215..228
FT                   /evidence="ECO:0007829|PDB:6WQX"
FT   HELIX           232..245
FT                   /evidence="ECO:0007829|PDB:6WQX"
SQ   SEQUENCE   253 AA;  28160 MW;  8B081DED6D2DC034 CRC64;
     MAAARATTPA DGEEPAPEAE ALAAARERSS RFLSGLELVK QGAEARVFRG RFQGRAAVIK
     HRFPKGYRHP ALEARLGRRR TVQEARALLR CRRAGISAPV VFFVDYASNC LYMEEIEGSV
     TVRDYIQSTM ETEKTPQGLS NLAKTIGQVL ARMHDEDLIH GDLTTSNMLL KPPLEQLNIV
     LIDFGLSFIS ALPEDKGVDL YVLEKAFLST HPNTETVFEA FLKSYSTSSK KARPVLKKLD
     EVRLRGRKRS MVG
//
